You are here: Industry Insights > suven

News List

CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir expresspharma
June 11, 2021
The anti-viral drug was initially developed for the treatment of influenza and has been repurposed to treat COVID-19.
Suven gets US court's approval to buy assets of Rising Pharmaceuticals firstwordpharma
April 15, 2019
Suven Life Sciences said it has received approval from a US bankruptcy court to buy assets of Rising ……
Suven secures product patents in China, Eurasia expressbpd
August 30, 2018
Suven Life Sciences has been granted a product patent each by China and Eurasia corresponding to a new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases. These patents are valid till 2034, the company said in
Suven gets product patents by Australia, Singapore financialexpress
May 21, 2018
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for treatment of disorders associated with neurodegenerative diseases.
Suven gets patents from HK, India, US on neurological molecule expressbpd
November 17, 2017
Suven Life Sciences has been granted a patent each from Hong Kong, S.A.R., China and the US and two from India for treatment of disorders associated with neurodegenerative diseases.
Singapore grants patent to Suven for neuro molecule biospectrumasia
October 23, 2017
The patent granted for the treatment of neurological diseases is valid through 2033.
Suven gets product patent for neurological drug expressbpd
October 11, 2017
Suven Life Sciences has received a patent from New Zealand for a drug used for the treatment of neuro-degenerative diseases.
Suven gets product patent from India and Japan biospectrumasia
September 27, 2017
The company is very pleased by the grant of these patents for the pipeline of molecules in CNS (central nervous system) arena.